Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.52 |
| ▸ | FNTA | P49354 | 2/20 | 0.52 |
| ▸ | FNTB | P49356 | 2/20 | 0.52 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL874195 | 1.00 | ALDH1A1 (0.69) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL5596597 | 1.00 | ALDH1A1 (0.69) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL18604017 | 1.00 | ALDH1A1 (0.69) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL1793466 | 1.00 | ALDH1A1 (0.69) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL5869130 | 0.98 | ALDH1A1 (0.67) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL29165442 | 0.98 | ALDH1A1 (0.67) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL8662149 | 0.89 | ALDH1A1 (0.79) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL14844960 | 0.89 | ALDH1A1 (0.79) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL8662151 | 0.89 | ALDH1A1 (0.79) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL30136431 | 0.89 | ALDH1A1 (0.55) | ALDH1A1ALOX15TRPV1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120078691-A | Fragrant oil for economic substitution of perfume rose essential oil and preparation method thereof | 广州宝士迪香精香料有限公司 | 2025-06-03 | — | — | CN | claimed |
| US-20250129312-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2025-04-24 | — | — | US | claimed |
| US-12209232-B2 | Consumer product compositions with perfume encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2025-01-28 | — | — | US | claimed |
| US-20230340375-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2023-10-26 | — | — | US | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| US-11732222-B2 | Consumer product compositions with perfume encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2023-08-22 | — | — | US | claimed |
| WO-2023095780-A1 | STINKBUG REPELLENT FOR PLANT APPLICATION | アース製薬株式会社 | 2023-06-01 | — | — | WO | claimed |
| US-20220364016-A1 | PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2022-11-17 | — | — | US | claimed |
| EP-4025675-A1 | A PERFUME OIL MIXTURE | Symrise AG (DE) | 2022-07-13 | — | — | EP | claimed |
| WO-2022128052-A1 | MEDICAMENT FOR FIGHTING INFLAMMATORY CONDITIONS OF HUMAN SKIN | SYMRISE AG (DE) | 2022-06-23 | — | — | WO | claimed |
| WO-2010017626-A1 | COMPOSITIONS COMPRISING TERPENE COMPOUNDS FOR TREATING NEGATIVE SENSORY PHENOMENA | ORIGIN BIOMED INC. (CA) | 2010-02-18 | — | — | WO | claimed |
| EP-2142182-A1 | COMPOSITION COMPRISING TERPENE COMPOUNDS AND METHODS FOR INHIBITING NERVE TRANSMISSION | Origin BioMed Inc. (CA) | 2010-01-13 | — | — | EP | claimed |
| WO-2008095297-A1 | COMPOSITION COMPRISING TERPENE COMPOUNDS AND METHODS FOR INHIBITING NERVE TRANSMISSION | ORIGIN BIOMED INC. (CA) | 2008-08-14 | — | — | WO | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
| WO-2004107859-A2 | NOVEL HERBAL MOSQUITO REPELLENT COMPOSITIONS | IYER GANESH NATRAJAN (IN) | 2004-12-16 | — | — | WO | claimed |
| US-20040223998-A1 | Insect repellent | IYER GANESH NATRAJAN (IN) | 2004-11-11 | — | — | US | claimed |
| US-20040176311-A1 | Composition and method for treating cancer | MO HUANBIAO (US) | 2004-09-09 | — | — | US | claimed |
| WO-2002098966-A2 | AROMATIC PRINCIPLES FOR IMPROVING THE STABILITY IN STORAGE AND/OR FOR IMPROVING THE SOLUBILITY OF POLYVINYL ALCOHOLS AND/OR POLYVINYL ALCOHOLS WITH BONDED CELLULOSE | DROM FRAGRANCES INTERNATIONAL KG (DE) | 2002-12-12 | — | — | WO | claimed |
| EP-1061907-A1 | MONOTERPENOID DERIVATIVES FOR TREATMENT OF CANCER | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2000-12-27 | — | — | EP | claimed |
| WO-1999045912-A1 | MONOTERPENOID DERIVATIVES FOR TREATMENT OF CANCER | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-09-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040223998-A1 | Insect repellent | LSS, BCHE, L3MBTL4 | ALDH1A1 4071/4885ALOX15 1246/4885TRPV1 1175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.